Cochrane · systematic review · CD013870
Phototherapy for atopic eczema
Musters, AH, Mashayekhi, S, Harvey, J, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
SkinAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
20
current version
GRADE rated
12
No studies
8
Included studies
NR
No studies 8 · 40%Ungraded 0 · 0%Very low 8 · 40%Low 4 · 20%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings table ‐ NB‐UVB compared to placebo for atopic eczema
Population: atopic eczema
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Physician‐assessed changes in clinical signs Summary of findings table ‐ NB‐UVB vs placebo | no estimate extracted | 1 study · 41 participants | Low Downgraded: risk of bias, imprecision |
Patient‐reported changes in symptoms Summary of findings table ‐ NB‐UVB vs placebo | RR 1.72 [1.1, 2.69] | 1 study · 40 participants | Low Downgraded: risk of bias, imprecision |
Investigator Global Assessment (short‐term) Summary of findings table ‐ NB‐UVB vs placebo | RR 2.81 [1.1, 7.17] | 1 study · 41 participants | Low Downgraded: risk of bias, imprecision |
Health‐related quality of life ‐ not measured Summary of findings table ‐ NB‐UVB vs placebo | no estimate extracted | NR | No studies |
Safety: withdrawals due to adverse events (short‐term) Summary of findings table ‐ NB‐UVB vs placebo | no estimate extracted | 3 studies · 89 participants | Low Downgraded: risk of bias, imprecision |
Summary of findings table ‐ NB‐UVB compared to UVA1 for atopic eczema
Population: atopic eczema
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Physician‐assessed changes in clinical signs (short‐term) Summary of findings table ‐ NB‐UVB vs UVA1 | no estimate extracted | 1 study · 46 participants | Very low Downgraded: risk of bias, imprecision |
Patient‐reported changes in symptoms Summary of findings table ‐ NB‐UVB vs UVA1 | no estimate extracted | 1 study · 46 participants | Very low Downgraded: risk of bias, imprecision |
Investigator Global Assessment ‐ not measured Summary of findings table ‐ NB‐UVB vs UVA1 | no estimate extracted | NR | No studies |
Health‐related quality of life Summary of findings table ‐ NB‐UVB vs UVA1 | no estimate extracted | 1 study · 46 participants | Very low Downgraded: risk of bias, imprecision |
Safety: withdrawal due to adverse events Summary of findings table ‐ NB‐UVB vs UVA1 | no estimate extracted | 1 study · 13 participants | Very low Downgraded: risk of bias, imprecision |
Summary of findings table ‐ NB‐UVB compared to PUVA for atopic eczema
Population: atopic eczema
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Physician‐assessed changes in clinical signs Summary of findings table ‐ NB‐UVB vs PUVA | no estimate extracted | 1 study · 20 participants | Very low Downgraded: risk of bias, imprecision |
Patient‐reported changes in symptoms ‐ not measured Summary of findings table ‐ NB‐UVB vs PUVA | no estimate extracted | NR | No studies |
Investigator Global Assessment Summary of findings table ‐ NB‐UVB vs PUVA | OR 1 [0.13, 7.89] | 1 study · 20 participants | Very low Downgraded: risk of bias, imprecision |
Health‐related quality of life ‐ not measured Summary of findings table ‐ NB‐UVB vs PUVA | no estimate extracted | NR | No studies |
Safety: withdrawal due to adverse events Summary of findings table ‐ NB‐UVB vs PUVA | no estimate extracted | 1 study · 20 participants | Very low Downgraded: risk of bias, imprecision |
Summary of findings table ‐ UVA1 compared to PUVA for atopic eczema
Population: atopic eczema
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Physician‐assessed changes in clinical signs Summary of findings table ‐ UVA1 vs PUVA | no estimate extracted | 1 study · 40 participants | Very low Downgraded: risk of bias, imprecision |
Patient‐reported changes in symptoms ‐ not measured Summary of findings table ‐ UVA1 vs PUVA | no estimate extracted | NR | No studies |
Investigator Global Assessment ‐ not measured Summary of findings table ‐ UVA1 vs PUVA | no estimate extracted | NR | No studies |
Health‐related quality of life ‐ not measured Summary of findings table ‐ UVA1 vs PUVA | no estimate extracted | NR | No studies |
Safety: withdrawals due to adverse events ‐ not measured Summary of findings table ‐ UVA1 vs PUVA | no estimate extracted | NR | No studies |